OrthoPediatrics Corp. has reached a significant milestone in its Global POISE Study, with over 600 implants now being monitored across more than 300 pediatric patients. This ongoing multi-center study ...
To date, more than 50% of the patients in the study have been enrolled in seven European countries. The study is testing AC102 as a novel, more effective treatment for sudden hearing loss with fewer ...
Research describes a computational model that captures the intricate muscular architecture of an octopus arm. Mechanical engineering PhD candidate Arman Tekinalp, fellow graduate student Seung Hyun ...
MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the ...
FRANKLIN LAKES, N.J., Nov. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient ...
SCYNEXIS, Inc. has announced the resumption of patient dosing in the Phase 3 MARIO study of ibrexafungerp, an oral antifungal medication, following the lifting of a clinical hold by the FDA. This ...
Whether they are a Siamese, Persian, Maine coon, or domestic shorthair, there are hundreds of millions of cats living with people around the world. But despite their popularity as pets, the history of ...
The Chosun Ilbo on MSNOpinion
Milestone? Flawed study killing dawn delivery
Ministry of Employment and Labor's Ryu Hyun-cheol, Head of the Occupational Safety and Health Bureau (vice-ministerial level) ...
BERLIN--(BUSINESS WIRE)--Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the study is to test the efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback